Literature DB >> 19018758

Scythe/BAT3 regulates apoptotic cell death induced by papillomavirus binding factor in human osteosarcoma.

Tomohide Tsukahara1, Shigeharu Kimura, Shingo Ichimiya, Toshihiko Torigoe, Satoshi Kawaguchi, Takuro Wada, Toshihiko Yamashita, Noriyuki Sato.   

Abstract

Papillomavirus binding factor (PBF) was first identified as a transcription factor regulating the promoter activity of human papillomavirus. We previously demonstrated that PBF is an osteosarcoma-associated antigen and 92% of osteosarcoma tissues express PBF in the nucleus. Moreover, PBF-positive osteosarcoma has a significantly poorer prognosis than that with negative expression of PBF. In the present study, we assessed the biological role of PBF in cell survival. Overexpression of PBF induced cell death-mediated lactate dehydrase (LDH) release from 293EBNA cells. Cleaved poly(ADP-ribose) polymerase and active caspase-3 were also detected. However, PBF-induced apoptosis did not affect caspase-9 activity. Next, to identify the apoptosis regulator of PBF, we screened a cDNA library constructed from mRNA of the osteosarcoma cell line OS2000 using a yeast two-hybrid system and isolated Scythe/BAT3. Scythe/BAT3 mRNA was detected in 56% of osteosarcoma tissues and ubiquitously in various normal tissues. Although Scythe/BAT3 was localized to the cytoplasm in normal tissue, it was localized to the nucleus in osteosarcoma tissue. PBF and Scythe/BAT3 also colocalized to the cytoplasm in 293T cells and the nucleus in OS2000. Furthermore, overexpression of Scythe/BAT3 suppressed cell death events that resulted from overexpression of PBF in OS2000, but not in 293EBNA cells. Thus, our results support the ideas that: (i) PBF could induce apoptotic cell death via a caspase-9-independent pathway; (ii) the apoptosis regulator Scythe/BAT3 is a PBF-associated molecule acting as a nucleus-cytoplasm shuttling protein; and (iii) colocalization of PBF and Scythe/BAT3 in the nucleus might be an important factor for survival of osteosarcoma cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19018758     DOI: 10.1111/j.1349-7006.2008.00991.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  27 in total

1.  E3 ubiquitin ligase activity and targeting of BAT3 by multiple Legionella pneumophila translocated substrates.

Authors:  Alexander W Ensminger; Ralph R Isberg
Journal:  Infect Immun       Date:  2010-06-14       Impact factor: 3.441

2.  A three-platelet mRNA set: MAX, MTURN and HLA-B as biomarker for lung cancer.

Authors:  Lele Liu; Xingguo Song; Xinyi Li; Linlin Xue; Shanshan Ding; Limin Niu; Li Xie; Xianrang Song
Journal:  J Cancer Res Clin Oncol       Date:  2019-09-24       Impact factor: 4.553

3.  Possible prognostic value of BORIS transcript variants ratio in laryngeal squamous cell carcinomas - a pilot study.

Authors:  Renata Novak Kujundžić; Ivana Grbeša; Mirko Ivkić; Božo Krušlin; Paško Konjevoda; Koraljka Gall Trošelj
Journal:  Pathol Oncol Res       Date:  2014-02-23       Impact factor: 3.201

4.  Bat3 facilitates H3K79 dimethylation by DOT1L and promotes DNA damage-induced 53BP1 foci at G1/G2 cell-cycle phases.

Authors:  Timothy P Wakeman; Qinhong Wang; Junjie Feng; Xiao-Fan Wang
Journal:  EMBO J       Date:  2012-02-28       Impact factor: 11.598

5.  Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.

Authors:  Shitao Li; Lingyan Wang; Michael Berman; Young-Yun Kong; Martin E Dorf
Journal:  Immunity       Date:  2011-09-08       Impact factor: 31.745

6.  The promoter for intestinal cell kinase is head-to-head with F-Box 9 and contains functional sites for TCF7L2 and FOXA factors.

Authors:  Thomas W Sturgill; Paul B Stoddard; Steven M Cohn; Marty W Mayo
Journal:  Mol Cancer       Date:  2010-05-11       Impact factor: 27.401

7.  Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.

Authors:  Tomohide Tsukahara; Makoto Emori; Kenji Murata; Takahisa Hirano; Norihiro Muroi; Masanori Kyono; Shingo Toji; Kazue Watanabe; Toshihiko Torigoe; Vitaly Kochin; Hiroko Asanuma; Hiroshi Matsumiya; Keiji Yamashita; Tetsuo Himi; Shingo Ichimiya; Takuro Wada; Toshihiko Yamashita; Tadashi Hasegawa; Noriyuki Sato
Journal:  J Biol Chem       Date:  2014-06-24       Impact factor: 5.157

8.  Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion.

Authors:  Manu Rangachari; Chen Zhu; Kaori Sakuishi; Sheng Xiao; Jozsef Karman; Andrew Chen; Mathieu Angin; Andrew Wakeham; Edward A Greenfield; Raymond A Sobel; Hitoshi Okada; Peter J McKinnon; Tak W Mak; Marylyn M Addo; Ana C Anderson; Vijay K Kuchroo
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

9.  Orientia tsutsugamushi Modulates Endoplasmic Reticulum-Associated Degradation To Benefit Its Growth.

Authors:  Kyle G Rodino; Lauren VieBrock; Sean M Evans; Hong Ge; Allen L Richards; Jason A Carlyon
Journal:  Infect Immun       Date:  2017-12-19       Impact factor: 3.441

10.  Dysregulation of Zinc Finger Protein 395 Contributes to the Pathogenesis of Chondrosarcoma.

Authors:  Changbao Chen; Hua Zhou; Zhongjun Liu; Xinlong Ma
Journal:  Onco Targets Ther       Date:  2021-06-01       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.